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ABSTRACT 
 
Analytical chemistry is the science that seeks ever improved means of measuring the chemical composition 
of natural and artificial materials. Netupitant Delayed emesis has been largely associated with the activation 
of tachykinin family neurokinin 1 receptors. Palonosetron is a selective serotonin 5-HT3 receptor antago-
nist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present 
both centrally and peripherally in turn inhibits the visceral afferent stimulation of the vomiting center. The 
mobile phase used was orthophosphoric and acetate 70% buffer pH 3 and 30% methanol. The assay of 
Netupitant and Palanosetron was performed with tablets and the % assay was found to be 100.08 and 
100.04, The linearity was found to be linear with a correlation coefficient of 0.999, the precision 0.8 and 0.3 
for Netupitant and Palanosetron which shows that the method is precise. The validation of developed 
method shows that the accuracy is well within the limit, which shows that the method is capable of showing 
good accuracy and reproducibility. The LOD and LOQ for Netupitant were found to be 3.02 and 9.98 and 
LOD and LOQ for Palanosetron was found to be 3.00 and 10.00. Thus, it shows that the method is stability 
indicating, sensitive, accurate, robust and precise. Hence, the developed HPLC method can be successfully 
applied to the pharmaceutical dosage form and can be used for routine analysis.  
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INTRODUCTION 
Analytical chemistry is the science that seeks ever im-
proved means of measuring the chemical composi-
tion of natural and artificial materials [1]. The princi-
ple advantage of HPLC compared to classical column 
chromatography is improved resolution of the sepa-
rated substance, faster separation times and the in-
creased accuracy, precision and sensitivity [2]. Netupi-
tant is a neurokinin 1 receptor antagonist. Delayed 
emesis (vomiting) has been largely associated with 
the activation of tachykinin family neurokinin 1 
(NK1) receptors (broadly distributed in the central 
and peripheral nervous systems) by substance. As 
shown in vitro and in vivo studies, netupitant inhibits 
substance P mediated responses [3]. Palonosetron acts 
as Antiemetic and anti nauseants. Palonosetron is a 
selective serotonin 5-HT3 receptor antagonist. The 
antiemetic activity of the drug is brought about 
through the inhibition of 5-HT3 receptors present 
both centrally and peripherally (GI tract).  
 
Figure 1: Structure of Netupitant 
 
Figure 2: Structure of Glecaprevir 
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It has been hypothesized that palonosetron's potency 
and long plasma half-life may contribute to its ob-
served efficacy in preventing delayed nausea and 
vomiting caused by moderately emetogenic cancer 
chemotherapy [4] .Literature reveals different meth-
ods for their analysis in the following formulations[5-
8] .But our present plan is to develop a new, simple, 
precise& accurate method for its analysis in formula-
tion after a detailed study a new RP-HPLC method 
was decided to be developed and validate it according 
to ICH guidelines[9] and to study photo stability stud-
ies according to ICH Q1B guidelines[10]. 
MATERIALS AND METHODS 
The materials used were HPLC, UV/VIS Spectropho-
tometer, pH meter, weighing machine, Pipettes, Bu-
rettes and Beakers. Nutipatant, Palonosetron KH2PO4 
Water and Methanol for HPLC Acetonitrile for HPLC 
Ortho phosphoric Acid. The Instruments and chemi-
cals used were of HPLC grade. 
Wave length selection 
UV spectrum of 10µg/ml Netupitant and Palono-
setron in diluents (mobile phase composition) was 
recorded by scanning in the range of 200nm to 
400nm. From the UV spectrum wavelength selected 
as 210nm. At this wavelength both the drugs show 
good absorbance. 
 
Figure 3: Scanned Spectrum Curve 
Preparation of mobile phase 
Accurately measured 700 ml (70%) of above buffer 
and 300 ml of Methanol HPLC (30%) were mixed and 
degassed in an ultrasonic water bath for 10 minutes 
and then filtered through 0.45µ filter under vacuum 
filtration. 
Preparation of Standard Solution 
Accurately weigh and transfer 300 mg of Netupitant 
and 0.5 mg of Palonosetron working standard into a 
10 ml clean dry volumetric flask add about 7 ml of Dil-
uent and sonicate to dissolve it completely and make 
volume up to the mark with the same solvent.  
Further pipette 0.3 ml of the above stock solutions 
into a 10ml volumetric flask and dilute up to the mark 
with diluent.  
Preparation of Sample Solution 
Accurately weigh and transfer 300 mg of Netupitant 
and 0.5 mg of Palonosetron working standard into a 
10 ml clean dry volumetric flask add about 7 ml of 
Diluent and sonicate to dissolve it completely and 
make volume up to the mark with the same solvent.  
Further pipette 0.3 ml of the above stock solutions 
into a 10ml volumetric flask and dilute up to the mark 
with diluent.  
Optimized Method 
The column used was YMC 4.6×150mm5µ, Mobile 
phase consists of 70% buffer pH 3 and 30% metha-
nol, Flow rate was 1.0 ml per min, Wavelength de-
tected at 210 nm, Injected volume was 20µl and 
Runtime noted as 8min. 
 
Figure 4: Chromatogram of optimized method 
Validation of Developed Method  
Assay: Inject 20 µl of the standard, sample into the 
chromatographic system and measure the areas for 
Netupitant and Palonosetron peaks and calculate the 
% Assay by using the formulae.  
𝐴𝑠𝑠𝑎𝑦% =
𝐴𝑇
𝐴𝑆
×
𝑊𝑆
𝐷𝑆
×
𝐷𝑇
𝑊𝑇
×
𝑃
100
×
𝐴𝑊
𝐿𝐶
× 100  
Table 1: Results of Assay for Netupitant and Palono-
setron 
Drug name Label Claim(mg) % Assay 
Netupitant 300 100.08 
Palonosetron 0.5 100.04 
Linearity 
Inject each level into the chromatographic system 
and measure the peak area. Plot a graph of peak area 
versus concentration (on X-axis concentration and on 
Y-axis Peak area) and calculate the correlation coeffi-
cient. Calibration graphs were shown in (Figure 5, 
Figure 6) and results are shown in (Table 2). 
Precision 
The standard solution was injected for six times and 
measured the area for all six Injections in HPLC. The 
%RSD for the area of six replicate injections was 
found to be within the specified limits. The precision 
results are represented in (Table 3). 
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Intermediate Precision (Ruggedness) 
There was no significant change in assay content and 
system suitability parameters at different conditions 
of ruggedness like day to day and system to system 
variation. The results are represented in (Table 5) 
Accuracy 
For accuracy determination, three different concen-
trations were prepared separately i.e. 50%, 100% 
and 150% for the analyte and chromatograms are 
recorded for the same. 
Calculate the Amount found and Amount added for 
Netupitant & Palonosetron and calculate the individ-
ual recovery and mean recovery values. % recovery 
was calculated and represented in (Table 6, Table 7). 
Limit of Detection for Netupitant and Palono-
setron 
The LOD and LOQ solutions was prepared injected, 
for three times and measured the area for all three in-
jections in HPLC. The %RSD for the area of six repli-
cate injections was found to be within the specified 
limits. 
Chromatograms were shown in the (Figure 6) and 
Results are shown in the (Table 8). The lowest con-
centration of the sample was prepared with respect 
to the base line noise and measured the signal to 
noise ratio. 
LOD: It is calculated by using following formula 
 3.3
𝑆𝐷
×
100.  
Limit of Quantification for Netupitant and Palono-
setron 
The lowest concentration of the sample was prepared 
with respect to the base line noise and measured the 
signal to noise ratio. The chromatograms were rec-
orded as show in (Figure 7) and results are shown in 
(Table 9). 
LOQ: It is calculated by using following formula 
10
𝑆𝐷
× 100 
Robustness 
The deliberate changes were done in the Flow rate, 
Mobile Phase composition, Temperature Variation 
was made to evaluate the impact on the method. The 
flow rate was varied at 1.1 ml/min to 0.9ml/min.The 
Organic composition in the Mobile phase was varied 
from ±10%. The results are shown in (Table 10, Table 
11, Table 12, Table 13). 
The standard and samples of Netupitant and Palono-
setron were injected by changing the conditions of 
chromatography. There was no significant change in 
the parameters like resolution, tailingfactor, asym-
metricfactor and plate count. 
Results for actual Mobile phase composition have 
been considered from Accuracy standard. The Reten-
tion time, USP plate count, USP tailing factor obtained 
for change of flow rate, variation in mobile phase was 
found to be within the acceptance criteria. Hence the 
method is robust. 
Degradation Studies 
The International Conference on Harmonization ICH 
Q1B guideline entitled stability testing of new drug 
substances and products requires that stress testing 
be carried out to elucidate the inherent stability char-
acteristics of the active substance. The result of deg-
radation studies is shown in (Table 14). 
Preparation of stock 
Accurately weigh and transfer 300 mg of Netupitant 
and 0.5 mg of Palonosetron working standard into a 
10 ml clean dry volumetric flask add about 7 mL of 
Diluent and sonicate to dissolve it completely and 
make volume up to the mark with the same solvent. 
(Stock solution) 
Hydrolytic degradation under acidic condition 
Pipette 0.3 ml of above solution into a 10ml volumet-
ric flask and 3 ml of 0.1N HCl was added. Then, the 
volumetric flask was kept at 60ºC for 6 hours and 
then neutralized with 0.1 N NaOH and make up to 
10ml with diluent. Filter the solution with 0.22 mi-
crons syringe filters and place in vials.  
Hydrolytic degradation under alkaline condition 
Pipette 0.3ml of above solution into a 10ml volumet-
ric and add 3ml of 0.1N NaOH was added in 10ml of 
volumetric flask. Then, the volumetric flask was kept 
at 60ºC for 6 hours and then neutralized with 0.1N 
HCl and make up to 10ml with diluent. Filter the so-
lution with 0.22 microns syringe filters and place in 
vials. 
Thermal induced degradation 
Netupitant and Palonosetron sample was taken in 
petridish and kept in Hot air oven at 1100 C for 24 
hours. Then the sample was taken and diluted with 
diluents and injected into HPLC and analyzed. 
Oxidative degradation 
Pipette 0.3ml above stock solution into a 10ml volu-
metric flask and 1ml of 3% w/v of hydrogen peroxide 
added in 10 ml of volumetric flask and the volume 
was made up to the mark with diluent. The volumet-
ric flask was then kept at room temperature for 15 
min. Filter the solution with 0.45 microns syringe fil-
ters and place in vials.  
Photo degradation 
Pipette 0.3 ml above stock solution into a 10ml volu-
metric flask and expose to sunlight for 24hrs and the 
volume was made up to the mark with diluent. Filter 
the solution with 0.45 microns syringe filters and 
place in vials. 
RESULTS AND DISCUSSIONS 
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The estimation of Netupitant and Palonosetran was 
done by RP-HPLC. The assay of Netupitant and 
Palonosetron was performed with tablets and the % 
assay was found to be 100.08 and 100.04, The linear-
ity of Netupitant and Palonosetron was found to be 
linear with a correlation coefficient of 0.999, the 
method show precision 0.8 and 0.3 for Netupitant 
and Palonosetron which shows that the method is 
precise. 
Table 2: Linearity for Netupitant and Palonosetron 
S. 
No 
Linear-
ity 
Level 
Con-
centra-
tion 
Area 
Con-
centra-
tion 
Area 
1 I 300 30018 0.5 2613 
2 II 600 58216 1 4969 
3 III 900 86174 1.5 7547 
4 IV 1200 117088 2 9909 
5 V 1500 147293 2.5 12640 
Correlation Co-
efficient 
0.999 0.999 
 
Figure 5: Calibration graph Netupitant 
 
Figure 6: Calibration graph Palonosetron 
Table 3: Precision results for Netupitant and Palono-
setron 
Injection 
Area for Netupi-
tant 
Area for Palono-
setron 
Injection-1 87799 7524 
Injection-2 86973 7519 
Injection-3 86232 7524 
Injection-4 87604 7581 
Injection-5 85975 7558 
Injection-6 87018 7565 
Average 86933.8 7545.2 
Standard Devi-
ation 
723.5 26.2 
%RSD 0.8 0.3 
Table 4: ID Precision results for Netupitant and 
Palonosetron 
Injection 
Area for Netupi-
tant 
Area for Palono-
setron 
Injection-1 86017 7508 
Injection-2 86172 7587 
Injection-3 86652 7576 
Injection-4 86680 7534 
Injection-5 86818 7558 
Injection-6 86585 7517 
Average 86933.8 7546.7 
Standard Devi-
ation 
723.5 32.1 
%RSD 0.8 0.4 
The intermediate precision is 0.8 and 0.4 for Netupi-
tant and Palonosetron which shows that the method 
is repeatable when performed in different days also. 
The total recovery was found to be 100.43% and 
100.50% for Netupitant and Palonosetron. The vali-
dation of developed method shows that the accuracy 
is well within the limit, which shows that the method 
is capable of showing good accuracy and reproduci-
bility.  
Table 5: Accuracy (recovery) data for Netupitant and 
Palonosetron 
% 
Conc 
Area 
Amount 
Added 
(mg) 
Amount 
Found 
(mg) 
% Re-
covery 
50% 43148.6 10 10.01  
100% 86625.0 20 20.09 100.43 
150% 130313.3 30 30.23  
50% 3818.7 5 5.04  
100% 7587 10 10.01 100.50 
150% 11447 15 15.10  
The LOD and LOQ for Netupitant were found to be 
3.02 and 9.98 and LOD and LOQ for Palonosetron was 
found to be 3.00 and 10.00. 
 
Figure 7: Chromatogram of Netupitant, Palonosetron 
showing LOD 
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Table 6: Flow variations for Netupitant and Palonosetron 
S. No Flow Rate (ml/min) 
Netupitant Palonosetron 
USP Plate Count USP Tailing USP Plate Count USP Tailing 
1 0.9 3962 1.17 3110 1.13 
2 1 3914.29 1.17 3017.92 1.13 
3 1.1 3199.71 1.14 2675.77 1.12 
Table 7: Organic phase variation for Netupitant and Palonosetron 
S. No 
Change in Organic Composition  
in the Mobile Phase 
Netupitant Palonosetron 
USP Plate Count USP Tailing USP Plate Count USP Tailing 
1 10% less 3591 1.42 2410 1.34 
2 *Actual 3914.29 1.17 3017.92 1.13 
3 10% more 3340.78 1.17 3341.82 1.18 
Table 8: Results of LOD and LOQ 
LOD 
Drug name Baseline noise(µV) Signal obtained (µV) S/N ratio 
Netupitant 58 175 3.02 
Palonosetron 58 174 3.00 
LOQ 
Drug name Baseline noise(µV) Signal obtained (µV) S/N ratio 
Netupitant 58 579 9.98 
Palonosetron 58 580 10.00 
Table 9: Degradation results for Netupitant and Palonosetron 
Sample Name Netupitant Palonosetron 
Area % Degraded Area % Degraded 
Standard 86056.0  7565.7  
Acid 81872 4.86 7239 4.32 
Base 81285 5.54 7298 3.54 
Peroxide 82049 4.66 7267 3.95 
Thermal 82411 4.24 7245 4.24 
Photo 82185 4.50 7264 3.99 
Table 10: Flow variations for Netupitant 
S. No Flow Rate (ml/min) System Suitability Results 
  USP Plate Count USP Tailing 
1 0.9 3962 1.17 
2 1 3914.29 1.17 
3 1.1 3199.71 1.14 
Table 11: Flow variations for Palonosetron 
S. No Flow Rate (ml/min) System Suitability Results 
  USP Plate Count USP Tailing 
1 0.9 3110 1.13 
2 1 3017.92 1.13 
3 1.1 2675.77 1.12 
 
Table 12: Organic phase variation for Netupitant 
S. No Flow Rate (ml/min) System Suitability Results 
  USP Plate Count USP Tailing 
1 10% less 3591 1.42 
2 *Actual 3914.29 1.17 
3 10% more 3340.78 1.17 
 
Table 13: Organic phase variation for Palonosetron 
S. No Flow Rate (ml/min) System Suitability Results 
  USP Plate Count USP Tailing 
1 10% less 2410 1.34 
2 *Actual 3017.92 1.13 
3 10% more 3341.82 1.18 
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Figure 8: Chromatogram of Netupitant, Palonosetron 
showing LOQ 
The robustness limit for mobile phase variation and 
flow rate variation are well within the limit, which 
shows that the method is having good system suita-
bility and precision under given set of conditions.  
Table 14: Degradation results 
Sample 
Name 
Netupitant Palonosetron 
Area 
% De-
graded 
Area 
% De-
graded 
Standard 161608.8  747503  
Acid 153252 5.17 719259 3.78 
Base 153532 5.00 719321 3.77 
Peroxide 152239 5.80 704978 5.69 
Thermal 157552 2.51 714851 4.37 
Photo 156452 3.19 714789 4.38 
 
CONCLUSION 
The developed HPLC method and validation was 
done according to ICH guidelines and photo stability 
studies were carried out according to ICH Q1B guide-
lines. Thus, it shows that the method is stability indi-
cating, sensitive, accurate, robust and precise. Hence, 
the method can be successfully applied to the phar-
maceutical dosage form and can be used for routine 
analysis. 
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